Bupropion
BUPROPION HYDROCHLORIDE (SR), Bupropion Hydrochloride (XL), Forfivo, WELLBUTRIN, bupropion
Norepinephrine-Dopamine Reuptake Inhibitor (NDRI)
NADAC/unit
$0.0676
No Shortage
Tier 1: 262.9%
26 Manufacturers
75 ANDAs
Bupropion hydrochloride extended-release tablets (XL) are an aminoketone antidepressant, indicated for: treatment of major depressive disorder (MDD) (1.1) prevention of seasonal affective disorder ....
vs. brand BUPROPION HYDROCHLORIDE (SR): Generic saves up to 99% per unit
Market Intelligence
2025-10-29 Class II Recall: Graviti Pharmaceuticals Private Limited
2024-07-17 Class II Recall: Amerisource Health Services LLC
2024-01-17 Class II Recall: Rising Pharma Holding, Inc.
2023-12-13 Class III Recall: SUN PHARMACEUTICAL INDUSTRIES INC
2023-10-25 Class III Recall: SUN PHARMACEUTICAL INDUSTRIES INC
Generic Manufacturers
ACCORD HEALTHCARE INCACTAVIS LABORATORIES FL INCALEMBIC PHARMACEUTICALS LTDANBISON LABORATORY CO LTDANNORA PHARMA PRIVATE LTDAPOTEX INCAUROBINDO PHARMA USA INCBAUSCH HEALTH US LLCCADILA PHARMACEUTICALS LTDEPIC PHARMA LLCGLAXOSMITHKLINEGRANULES PHARMACEUTICALS INCGRAVITI PHARMACEUTICALS PRIVATE LTDHERITAGE PHARMA LABS INCIMPAX LABORATORIES INCIPCA LABORATORIES LTDLUPIN LTDMICRO LABS LTDPRINSTON PHARMACEUTICAL INCSANDOZ INCSCIEGEN PHARMACEUTICALS INCSENORES PHARMACEUTICALS INCSINOTHERAPEUTICS INCTWI PHARMACEUTICALS INCWATSON LABORATORIES INCWOCKHARDT LTDYICHANG HUMANWELL PHARMACEUTICAL CO LTDZHEJIANG JUTAI PHARMACEUTICAL CO LTDZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.